275 related articles for article (PubMed ID: 19397467)
1. Clopidogrel-induced hepatocellular injury and cholestatic jaundice in an elderly patient: case report and review of the literature.
Goyal RK; Srivastava D; Lessnau KD
Pharmacotherapy; 2009 May; 29(5):608-12. PubMed ID: 19397467
[TBL] [Abstract][Full Text] [Related]
2. Successful use of clopidogrel for cerebrovascular accident in a patient with suspected ticlopidine-induced hepatotoxicity.
Zeolla MM; Carson JJ
Ann Pharmacother; 1999 Sep; 33(9):939-41. PubMed ID: 10492495
[TBL] [Abstract][Full Text] [Related]
3. Rash with both clopidogrel and ticlopidine in two patients following percutaneous coronary intervention with drug-eluting stents.
Makkar K; Wilensky RL; Julien MB; Herrmann HC; Spinler SA
Ann Pharmacother; 2006 Jun; 40(6):1204-7. PubMed ID: 16684808
[TBL] [Abstract][Full Text] [Related]
4. Clopidogrel desensitization: case report and review of published protocols.
Owen P; Garner J; Hergott L; Page RL
Pharmacotherapy; 2008 Feb; 28(2):259-70. PubMed ID: 18225971
[TBL] [Abstract][Full Text] [Related]
5. Hydralazine-induced cholestatic hepatitis.
Hassan A; Hammad R; Cucco R; Niranjan S
Am J Ther; 2009; 16(4):371-3. PubMed ID: 19092641
[TBL] [Abstract][Full Text] [Related]
6. Clopidogrel-induced hepatotoxicity after percutaneous coronary stenting.
Chau TN; Yim KF; Mok NS; Chan WK; Leung VK; Leung MF; Lai ST
Hong Kong Med J; 2005 Oct; 11(5):414-6. PubMed ID: 16219965
[TBL] [Abstract][Full Text] [Related]
7. [Late-appearing cholestatic icterus after a month of treatment with ticlopidine].
Placci A; Melandri G; Cecilioni L; Valgimigli M; Bolondi L; Branzi A
Ital Heart J Suppl; 2001 Nov; 2(11):1240-2. PubMed ID: 11775418
[TBL] [Abstract][Full Text] [Related]
8. Clopidogrel-induced hepatotoxicity and fever.
Ng JA; Goldberg N; Tafreshi MJ
Pharmacotherapy; 2006 Jul; 26(7):1023-6. PubMed ID: 16878371
[TBL] [Abstract][Full Text] [Related]
9. Thrombotic and bleeding events after coronary stenting according to clopidogrel and aspirin platelet reactivity: VerifyNow French Registry (VERIFRENCHY).
Rangé G; Yayehd K; Belle L; Thuaire C; Richard P; Cazaux P; Barbou F; Köning R; Chassaing S; Teiger E; Berthier R; Decomis MP; Claudel JP; Delarche N; Brunel P; De Poli F; Dupouy P; Beygui F; Albert F; Collet JP; Montalescot G;
Arch Cardiovasc Dis; 2014 Apr; 107(4):225-35. PubMed ID: 24794216
[TBL] [Abstract][Full Text] [Related]
10. Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial.
Mehta SR; Tanguay JF; Eikelboom JW; Jolly SS; Joyner CD; Granger CB; Faxon DP; Rupprecht HJ; Budaj A; Avezum A; Widimsky P; Steg PG; Bassand JP; Montalescot G; Macaya C; Di Pasquale G; Niemela K; Ajani AE; White HD; Chrolavicius S; Gao P; Fox KA; Yusuf S;
Lancet; 2010 Oct; 376(9748):1233-43. PubMed ID: 20817281
[TBL] [Abstract][Full Text] [Related]
11. Clopidogrel treatment in a patient with ticlopidine-induced hepatitis following percutaneous coronary stenting.
Anselmino M; Moretti C; Ravera L; Sheiban I
Minerva Cardioangiol; 2010 Apr; 58(2):277-80. PubMed ID: 20440256
[TBL] [Abstract][Full Text] [Related]
12. Ticlopidine-induced cholestatic hepatitis.
Skurnik YD; Tcherniak A; Edlan K; Sthoeger Z
Ann Pharmacother; 2003 Mar; 37(3):371-5. PubMed ID: 12639165
[TBL] [Abstract][Full Text] [Related]
13. Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen).
Park KW; Kang SH; Park JJ; Yang HM; Kang HJ; Koo BK; Park BE; Cha KS; Rhew JY; Jeon HK; Shin ES; Oh JH; Jeong MH; Kim S; Hwang KK; Yoon JH; Lee SY; Park TH; Moon KW; Kwon HM; Chae IH; Kim HS
JACC Cardiovasc Interv; 2013 Sep; 6(9):932-42. PubMed ID: 24050860
[TBL] [Abstract][Full Text] [Related]
14. Short-term follow-up of tirofiban as alternative therapy for urgent surgery patients with an implanted coronary drug-eluting stent after ST-elevation myocardial infarction.
Xia JG; Qu Y; Shen H; Liu XH
Coron Artery Dis; 2013 Sep; 24(6):522-6. PubMed ID: 23900046
[TBL] [Abstract][Full Text] [Related]
15. Clopidogrel for prevention of major cardiac events after coronary stent implantation: 30-day and 6-month results in patients with smaller stents.
Calver AL; Blows LJ; Harmer S; Dawkins KD; Gray HH; Morgan JH; Simpson IA
Am Heart J; 2000 Sep; 140(3):483-91. PubMed ID: 10966552
[TBL] [Abstract][Full Text] [Related]
16. [Ticlopidine-induced cholestasis].
Meyer MI; Kuhn M; Bühler H; Bertschinger P
Schweiz Med Wochenschr; 1999 Oct; 129(39):1405-9. PubMed ID: 10542998
[TBL] [Abstract][Full Text] [Related]
17. Ticlopidine-induced severe cholestatic hepatitis.
Wu MS; Chan P; Lien GS; Cheng YS; Pan S
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Aug; 63(8):663-6. PubMed ID: 10969455
[TBL] [Abstract][Full Text] [Related]
18. Fatal liver injury associated with clopidogrel.
Kastalli S; El Aïdli S; Zaïem A; ben Abdallah H; Daghfous R
Fundam Clin Pharmacol; 2010 Aug; 24(4):433-5. PubMed ID: 19895648
[TBL] [Abstract][Full Text] [Related]
19. An idiosyncratic reaction to clopidogrel.
Kapila A; Chhabra L; Locke AD; Patel P; Khanna A; Reddy CM; Young MF
Perm J; 2015; 19(1):74-6. PubMed ID: 25663208
[TBL] [Abstract][Full Text] [Related]
20. [Clopidogrel- induced hepatotoxicity in hemodialyzed patient: a case report].
Papagni S; Bonifati C; Dagostino F; Murgo AM
G Ital Nefrol; 2016; 33(1):. PubMed ID: 26913747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
